Clinical success of anti-infective combination therapy compare to monotherapy in patients with carbapenem-resistant Pseudomonas aeruginosa infection: a 10-years retrospective study

Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has become a major public health concern. The recommendations for monotherapy and combination therapy in the current guidelines lack sufficient evidence to support them. The primary objective of this study is to determine the ef...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC infectious diseases Ročník 24; číslo 1; s. 248 - 10
Hlavní autori:	Chen, Jialong, Lin, Jing, Weng, Jianzhen, Ju, Yang, Li, Yanming
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 23.02.2024 BioMed Central Ltd Springer Nature B.V BMC
Predmet:	Adult Anti-Bacterial Agents - therapeutic use Antibiotics Antiinfectives and antibacterials Antimicrobial agents Blood pressure Carbapenem-resistant Pseudomonas aeruginosa Carbapenems Carbapenems - therapeutic use Combination therapy Comorbidity Comparative analysis Critical care Disease Drug therapy Drug therapy, Combination Effectiveness Ethnicity Humans Infectious Diseases Intensive care Internal Medicine Length of stay Medical Microbiology Medical prognosis Medicine Medicine & Public Health Monotherapy Mortality Nosocomial infections Parasitology Patients Pharmacology, Experimental Pneumonia Pseudomonas aeruginosa Pseudomonas aeruginosa infections Pseudomonas Infections - drug therapy Public health Regression analysis Retrospective Studies Risk factors Sepsis Structured Query Language-SQL Success Survival analysis Therapy Tropical Medicine Ventilators China Carbapenem-resistant Effectiveness Combination therapy Monotherapy Carbapenem-resistant Pseudomonas aeruginosa
ISSN:	1471-2334, 1471-2334
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!